No placebo-controlled human trial was identified for weight management, diabetes, fatty liver disease, sarcopenia, athletic performance or healthy ageing
The most important factor is consistency of timing and route day to day, since the mechanism works cumulatively rather than as an acute event to time around a meal
Non-Stimulant Pathway Unlike many fat loss aids, this peptide does not rely on caffeine or thermogenic stimulants, making it suitable for those sensitive to these ingredients
Semaglutide or Tirzepatide: GLP-1 receptor agonists work through entirely different mechanisms (appetite suppression, glucose regulation, delayed gastric emptying) compared to AOD-9604s direct lipolytic effects
Direccin C/ Torras i Pujalt 1, Planta 0 Clnica Sagrada Familia, consultorio n